Evozyne, Inc.
Biotechnology
Evozyne is a biotechnology company specializing in the creation of novel protein systems to address critical challenges in therapeutic development. Utilizing generative AI and principles of evolution, Evozyne designs high-performance, adaptive proteins for commercial applications, particularly in healthcare and environmental sustainability.
Founded: 2020
Mike Gamson Chief Executive Officer |
Zach Serber Ph.D Chief Operating Officer |
Aris Theologis Chief Business Officer |
Uri Herzberg Ph.D Chief Drug Discover Officer |
Rama Ranganathan Ph.D Co-Founder & Chief Strategic Officer |